Supplementary Figure S1 from A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)